319 related articles for article (PubMed ID: 18841184)
1. High prevalence of gout in patients with Type 2 diabetes: male sex, renal impairment, and diuretic use are major risk factors.
Suppiah R; Dissanayake A; Dalbeth N
N Z Med J; 2008 Oct; 121(1283):43-50. PubMed ID: 18841184
[TBL] [Abstract][Full Text] [Related]
2. Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile.
Choi HK; De Vera MA; Krishnan E
Rheumatology (Oxford); 2008 Oct; 47(10):1567-70. PubMed ID: 18710901
[TBL] [Abstract][Full Text] [Related]
3. Gout in renal transplant recipients.
Stamp L; Ha L; Searle M; O'Donnell J; Frampton C; Chapman P
Nephrology (Carlton); 2006 Aug; 11(4):367-71. PubMed ID: 16889578
[TBL] [Abstract][Full Text] [Related]
4. Hypertensive women with the metabolic syndrome are at risk of renal insufficiency more than men in general population.
Korhonen P; Aarnio P; Vesalainen R; Saaresranta T; Kautiainen H; Järvenpää S; Kantola I
J Hum Hypertens; 2009 Feb; 23(2):97-104. PubMed ID: 18784736
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome-related conditions among people with and without gout: prevalence and resource use.
Novak S; Melkonian AK; Patel PA; Kleinman NL; Joseph-Ridge N; Brook RA
Curr Med Res Opin; 2007 Mar; 23(3):623-30. PubMed ID: 17355743
[TBL] [Abstract][Full Text] [Related]
6. Anemia, hypoalbuminemia, and renal impairment as predictors of bleeding complications in patients receiving anticoagulation therapy for nonvalvular atrial fibrillation: a secondary analysis.
Abdelhafiz AH; Myint MP; Tayek JA; Wheeldon NM
Clin Ther; 2009 Jul; 31(7):1534-9. PubMed ID: 19695402
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for development of impaired renal function in Type 2 diabetes mellitus patients in primary care.
Naushahi MJ; de Grauw WJ; Avery AJ; van Gerwen WH; van de Lisdonk EH; van Weel C
Diabet Med; 2004 Oct; 21(10):1096-101. PubMed ID: 15384956
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with musculoskeletal disability and chronic renal failure in clinically diagnosed primary gout.
Alvarez-Nemegyei J; Cen-Pisté JC; Medina-Escobedo M; Villanueva-Jorge S
J Rheumatol; 2005 Oct; 32(10):1923-7. PubMed ID: 16206348
[TBL] [Abstract][Full Text] [Related]
9. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
10. Impact of a rheumatology consultation service on the diagnostic accuracy and management of gout in hospitalized patients.
Barber C; Thompson K; Hanly JG
J Rheumatol; 2009 Aug; 36(8):1699-704. PubMed ID: 19567626
[TBL] [Abstract][Full Text] [Related]
11. Trends in the manifestations of gout in Taiwan.
Chen SY; Chen CL; Shen ML; Kamatani N
Rheumatology (Oxford); 2003 Dec; 42(12):1529-33. PubMed ID: 13130146
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
Fiuza M; Cortez-Dias N; Martins S; Belo A;
Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
[TBL] [Abstract][Full Text] [Related]
13. The burden of anaemia in type 2 diabetes and the role of nephropathy: a cross-sectional audit.
Thomas MC; MacIsaac RJ; Tsalamandris C; Molyneaux L; Goubina I; Fulcher G; Yue D; Jerums G
Nephrol Dial Transplant; 2004 Jul; 19(7):1792-7. PubMed ID: 15102962
[TBL] [Abstract][Full Text] [Related]
14. Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register.
Nilsson PM; Cederholm J; Eeg-Olofsson K; Eliasson B; Zethelius B; Fagard R; Gudbjörnsdóttir S;
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):506-12. PubMed ID: 19561510
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of chronic gout in Northern Sulawesi, Indonesia.
Padang C; Muirden KD; Schumacher HR; Darmawan J; Nasution AR
J Rheumatol; 2006 Sep; 33(9):1813-7. PubMed ID: 16960942
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of gout and related risk factors in Taiwan's Aborigines.
Chang SJ; Ko YC; Wang TN; Chang FT; Cinkotai FF; Chen CJ
J Rheumatol; 1997 Jul; 24(7):1364-9. PubMed ID: 9228138
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of gout: is the incidence rising?
Arromdee E; Michet CJ; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2002 Nov; 29(11):2403-6. PubMed ID: 12415600
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
[TBL] [Abstract][Full Text] [Related]
20. First acute gout attacks commonly precede features of the metabolic syndrome.
Hernández-Cuevas CB; Roque LH; Huerta-Sil G; Rojas-Serrano J; Escudero A; Perez LL; Collantes-Estevez E; Vázquez Mellado J
J Clin Rheumatol; 2009 Mar; 15(2):65-7. PubMed ID: 19265347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
